###begin article-title 0
###xml 90 91 90 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3">S&#8414;</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair*Sâƒž
###end article-title 0
###begin p 1
###xml 156 182 156 182 <email xmlns:xlink="http://www.w3.org/1999/xlink">s.jackson@gurdon.cam.ac.uk</email>
 To whom correspondence should be addressed: Gurdon Institute, Tennis Court Road, Cambridge CB2 1QN, UK. Tel.: 44-1223-334102; Fax: 44-1223-334089; E-mail: s.jackson@gurdon.cam.ac.uk.
###end p 1
###begin p 2
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
###xml 4 5 4 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 11 12 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 268 269 268 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 1008 1013 <span type="species:ncbi:9606">human</span>
###xml 1084 1089 <span type="species:ncbi:4932">yeast</span>
In G0 and G1, DNA double strand breaks are repaired by nonhomologous end joining, whereas in S and G2, they are also repaired by homologous recombination. The human CtIP protein controls double strand break (DSB) resection, an event that occurs effectively only in S/G2 and that promotes homologous recombination but not non-homologous end joining. Here, we mutate a highly conserved cyclin-dependent kinase (CDK) target motif in CtIP and reveal that mutating Thr-847 to Ala impairs resection, whereas mutating it to Glu to mimic constitutive phosphorylation does not. Moreover, we show that unlike cells expressing wild-type CtIP, cells expressing the Thr-to-Glu mutant resect DSBs even after CDK inhibition. Finally, we establish that Thr-847 mutations to either Ala or Glu affect DSB repair efficiency, cause hypersensitivity toward DSB-generating agents, and affect the frequency and nature of radiation-induced chromosomal rearrangements. These results suggest that CDK-mediated control of resection in human cells operates by mechanisms similar to those recently established in yeast.
###end p 4
###begin p 5
###xml 39 57 39 57 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Cancer Research UK</grant-sponsor>
###xml 66 84 66 84 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">European Community</grant-sponsor>
###xml 86 115 86 115 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Integrated Project DNA repair</grant-sponsor>
###xml 123 142 123 142 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">LSHG-CT-2005-512113</grant-num>
###xml 148 191 148 191 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Genomic Instability in Cancer and Precancer</grant-sponsor>
###xml 199 220 199 220 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">HEALTH-F2-2007-201630</grant-num>
###xml 240 303 240 303 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Biotechnology and Biological Sciences Research Council Research</grant-sponsor>
###xml 310 320 310 320 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">BBF0016651</grant-num>
This work was supported by grants from Cancer Research UK and the European Community (Integrated Project DNA repair, Grant LSHG-CT-2005-512113, and Genomic Instability in Cancer and Precancer, Grant HEALTH-F2-2007-201630) (to S. P. J.) and Biotechnology and Biological Sciences Research Council Research Grant BBF0016651 (to P. H.).
###end p 5
###begin p 6
The on-line version of this article (available at ) contains five supplemental figures.
###end p 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 7
###begin p 8
###xml 31 32 31 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">2</xref>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 300 301 300 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 495 496 495 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 502 503 502 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 559 560 559 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 658 659 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 745 746 745 746 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
DNA double strand breaks (DSBs)2 are highly cytotoxic lesions that can lead to mutations, chromosomal aberrations, or cell death. Defects in DSB signaling and/or repair can cause pathologies, including neurodegenerative disease and cancer predisposition. DSBs are repaired by two main mechanisms (1, 2): non-homologous end joining (NHEJ) and homologous recombination (HR). NHEJ ligates broken DNA ends without requiring extensive sequence complementarity and assumes the greatest importance in G0 and G1 (3). By contrast, HR is generally restricted to S and G2, where it can ensure accurate repair by using sister chromatid sequences as the repair template (4-6). Such cell cycle control of DSB repair is important because if HR is employed in G1, it can generate gross chromosomal rearrangements by using spurious homologous sequences as repair templates.
###end p 8
###begin p 9
###xml 251 252 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 262 263 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 265 266 265 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 553 578 553 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe</italic>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 989 990 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1181 1205 1181 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 196 201 <span type="species:ncbi:4932">yeast</span>
###xml 334 339 <span type="species:ncbi:4932">yeast</span>
###xml 553 578 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 1181 1205 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 1210 1216 <span type="species:ncbi:9606">humans</span>
Although various mechanisms likely control HR, a prime site of regulation is at the level of 5' to 3' DSB resection. Resection is needed for HR but not for NHEJ and is governed by CDK activity in yeast and mammalian cells, occurring effectively in S/G2 but not G0/G1 (5-7). Recent work has shown that a key target for this control in yeast is the Sae2 protein, which is phosphorylated on Ser-267 by CDK to promote resection (8). Notably, Sae2 counterparts have been identified in other organisms, including vertebrates (9-12), and with the exception of Schizosaccharomyces pombe Ctp1 (9), they all share a short homologous region in their C termini containing a CDK consensus site that aligns with Ser-267 of Sae2 (10-12). We have recently shown that mutating Sae2 Ser-267 to Ala to prevent its phosphorylation impairs resection and consequently reduces HR, whereas altering Ser-267 to Glu mimics constitutive phosphorylation and allows some resection even in the absence of CDK activity (8). Here, we carry out analogous studies on the equivalent CDK consensus motif of CtIP and thus provide evidence that CDK-mediated control of DSB resection operates by conserved mechanisms in Saccharomyces cerevisiae and humans.
###end p 9
###begin title 10
EXPERIMENTAL PROCEDURES
###end title 10
###begin p 11
###xml 0 51 0 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Culture, siRNA Transfection, and Cell Survival</italic>
###xml 418 420 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 471 472 470 471 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 656 658 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 192 198 <span type="species:ncbi:9913">bovine</span>
Cell Culture, siRNA Transfection, and Cell Survival-U2OS cells stably expressing GFP-CtIP variants were grown in Dulbecco's modified Eagle's medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (BioSera), 100 units/ml penicillin, and 100 mug/ml streptomycin (Sigma-Aldrich) supplemented with 0.5 mg/ml G418 (Invitrogen). siRNA duplex against CtIP (GCUAAAACAGGAACGAAUC; MWG Biotec) was previously described (11), and siRNA transfections were performed with 50 nm final oligonucleotide concentrations and Oligofectamine (Invitrogen). Experiments were performed 48 h after transfection. Cell survival assays were performed as described previously (11).
###end p 11
###begin p 12
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunoblotting</italic>
###xml 68 69 68 69 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
Immunoblotting-Extracts were prepared in 4% SDS, 20% glycerol, 120 mm Tris-HCl, pH 6.8, and proteins were resolved by SDS-PAGE and transferred to nitrocellulose followed by immunoblotting. R. Baer (Columbia University) provided a mouse monoclonal CtIP antibody, and X. Yu (University of Michigan Medical School) provided the phospho-Ser-327 antibody. Other antibodies were from AbCam (Mre11, RPA32), Bethyl Laboratories (RPA32-pS4/S8), Santa Cruz Biotechnology (BRCA1, GST), and Roche Applied Science (GFP).
###end p 12
###begin p 13
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In Vitro CDK Assay</italic>
###xml 255 257 251 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
In Vitro CDK Assay-A GST-fused version of the CtIP C-terminal region (residues 790-897) was affinity-purified with glutathione-Sepharose 4B (Amersham Biosciences), incubated with recombinant CDK2/cyclin A (Upstate Biotechnology) in the presence of [gamma-32P]ATP according to the manufacturer's instructions, separated by 10% SDS-PAGE, and transferred to a nitrocellulose membrane. Proteins were detected with an anti-GST antibody, and phosphorylation was visualized by autoradiography.
###end p 13
###begin p 14
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Laser Microirradiation</italic>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
Laser Microirradiation-Generation of localized DNA damage by laser was done as previously (13). Cells were fixed with 4% paraformaldehyde (w/v) in PBS for 15 min, treated with 0.2% Triton X-100 in PBS for 10 min, washed three times with PBS, and then co-immunostained with antibodies against gammaH2AX (Cell Signaling Technology), cyclin A (Santa Cruz Biotechnology), and RPA32 (Lab Vision Corp.). For detection, Alexa Fluor 594- (red) and 647- (far red) conjugated secondary antibodies were used (Molecular Probes, Paisley, UK). Samples were visualized with an Olympus inverted confocal laser microscope by sequential scanning of the emission channels.
###end p 14
###begin p 15
###xml 0 29 0 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunofluorescence Microscopy</italic>
###xml 173 174 172 173 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 300 301 299 300 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 321 322 320 321 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 332 333 331 332 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 343 344 342 343 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 349 350 348 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 357 358 356 357 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Immunofluorescence Microscopy-For RPA focus detection, U2OS cells expressing GFP-CtIP fusions were transfected with CtIP siRNA, and 2 days later, they were treated with 1 mum camptothecin or 10 Gy of ionizing radiation (IR) and collected 1 h afterward. Following pre-extraction for 5 min on ice (25 mm Hepes, pH 7.4, 50 mm NaCl, 1 mm EDTA, 3 mm MgCl2, 300 mm sucrose, and 0.5% Triton X-100), cells were fixed with 4% paraformaldehyde (w/v) in PBS for 15 min. Coverslips were washed three times with PBS and then co-immunostained as above.
###end p 15
###begin p 16
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Random Plasmid Integration</italic>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
Random Plasmid Integration-Assays were as described previously with minor modifications (14). One day after transfection with CtIP siRNA, cells were transfected with PvuI-linearized pCDNA4-HISMAX-LacZ (Invitrogen). The following day, cells were collected, counted, and plated on three plates, one containing 1 mg/ml Zeocin. One day after plating, cells on a plate lacking Zeocin were assessed for transfection efficiency by a beta-galactosidase staining kit (Invitrogen), and the other two plates were incubated for 10-14 days at 37 degreesC for colony formation. Colonies were stained with 0.5% crystal violet, 20% ethanol and counted. Integration events (number of colonies on plates containing Zeocin) were normalized to transfection (number of beta-galactosidase-positive cells) and plating efficiencies (colonies after 14 days of growth without Zeocin).
###end p 16
###begin p 17
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Chromosomal Analyses</italic>
###xml 233 234 227 228 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 350 351 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 576 577 570 571 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Chromosomal Analyses-Following CtIP depletion, cells were exposed to 2 Gy of IR and then allowed to recover at 37 degreesC for 8 h in fresh medium before chromosome preparation. Within these 8 h, cells were treated with caffeine (2 mm final concentration) for the last 5 h to allow cells with gross chromosomal rearrangements (GCRs) to overcome the G2/M checkpoint and enter mitosis, and for the last 3 h, they were treated with Colcemid (KaryoMAX, Invitrogen; final concentration 0.1 mg/ml) to induce chromosome condensation. Cells were then harvested and treated with 0.075 m KCl for 10 min at 37 degreesC, fixed in methanol/acetic acid (3/1), washed twice with methanol/acetic acid (3/1), and then spread on a glass microscope slide, air-dried, and 4',6-diamidino-2-phenylindole-stained.
###end p 17
###begin title 18
RESULTS
###end title 18
###begin p 19
###xml 0 45 0 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtIP Function Is Impaired by Mutating Thr-847</italic>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 217 224 217 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 700 701 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 694 701 694 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 803 804 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 797 804 797 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 191 196 <span type="species:ncbi:9606">human</span>
CtIP Function Is Impaired by Mutating Thr-847-A similar CDK consensus sequence to that encompassing Sae2 Ser-267 is present in nearly all Sae2/CtIP orthologues, with the analogous residue of human CtIP being Thr-847 (Fig. 1A). To investigate the potential functions of Thr-847 phosphorylation, we generated stable U2OS cell clones that expressed siRNA-resistant wild-type GFP-tagged CtIP, or siRNA-resistant CtIP derivatives in which Thr-847 was changed to an unphosphorylatable Ala (GFP-CtIP-T847A) or to a negatively charged Glu residue (GFP-CtIP-T847E) to mimic constitutive phosphorylation. We selected for clones that expressed the engineered protein at similar levels to endogenous CtIP (Fig. 1B), and a stable cell line expressing GFP alone was generated as a negative control. As shown in Fig. 1B, transfection with the CtIP siRNA oligonucleotide effectively depleted endogenous CtIP but not the siRNA-resistant GFP-CtIP fusion proteins.
###end p 19
###begin p 20
###xml 974 975 962 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 968 975 956 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1218 1226 1206 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1308 1309 1296 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1302 1309 1290 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 1559 1560 1547 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1553 1560 1541 1548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
As an approach to detect phosphorylation on CtIP Thr-847, we made several attempts to generate phospho-specific antisera against this site. When we assessed the resulting antisera by Western immunoblotting, however, this strategy was undermined by the antibodies recognizing additional phosphorylation sites on CtIP (data not shown). By contrast, when we used the antibodies in indirect immunofluorescence studies, we observed that a subpopulation (approximately60%) of cells expressing wild-type GFP-CtIP exhibited a strongly positive signal, whereas staining was much weaker in cells expressing the CtIP variant, GFP-CtIP-T847A (we assume that the remaining, weak signal observed with the T847A mutant was due to cross-reactivity with other phosphorylation sites). Consistent with the strongly positive signal reflecting CDK-mediated modification of CtIP on Thr-847, this signal was markedly diminished when cells were pretreated with the CDK inhibitor roscovitine (Fig. 1C). To further substantiate the idea that CtIP is phosphorylated on Thr-847 by CDK, we purified bacterially expressed wild-type and Thr-847 mutated versions of a C-terminal fragment of CtIP tagged with GST. Next, we subjected these proteins to in vitro CDK phosphorylation assays with purified CDK/cyclin A and radioactive ATP (Fig. 1D). Notably, when the wild-type CtIP fragment was used, radioactive phosphate was incorporated in a CDK-dependent manner. By contrast, little or no radioactivity was incorporated into the CtIP derivative bearing the Thr-847 Thr-to-Ala mutation (Fig. 1D). Collectively, these findings thereby provided strong support for CtIP Thr-847 indeed being a CDK target.
###end p 20
###begin p 21
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 498 505 498 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 678 679 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 672 679 672 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1026 1027 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1207 1208 1203 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1201 1208 1197 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1210 1220 1206 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black bars</italic>
###xml 1505 1506 1497 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1499 1506 1491 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 1508 1518 1500 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">white bars</italic>
To assess the potential functions of CtIP Thr-847 phosphorylation, we siRNA-depleted endogenous CtIP from the cell clones expressing GFP-CtIP variants (Fig. 1B) and then assessed their survival following acute (1 h) treatments with various concentrations of camptothecin. In agreement with our previous data (8), cells expressing the T847A CtIP mutant were more sensitive to camptothecin than cells expressing wild-type CtIP and were essentially as sensitive as control cells expressing GFP alone (Fig. 2A). By contrast, cells expressing the T847E CtIP mutant were not hypersensitive to camptothecin and were, in fact, more resistant than cells expressing wild-type CtIP (Fig. 2A). As camptothecin cytotoxicity depends on DNA replication, it was possible that the above differences in survival reflected different cell cycle distributions among the various cell clones. However, fluorescence-activated cell sorter analyses revealed only minor differences in cell cycle distributions between the cell lines (supplemental Fig. 1A). Furthermore, all cell lines exhibited similar levels of camptothecin-induced DSB formation, as assessed by the appearance of phosphorylated histone H2AX (gammaH2AX) foci (Fig. 2B, black bars). However, when we analyzed the same gammaH2AX-positive cells for formation of RPA-coated ssDNA, significant differences were observed. RPA foci formed efficiently in cells expressing wild-type CtIP or the T847E mutant but not in cells expressing the T847A mutant or GFP alone (Fig. 2B, white bars). These results indicated that the ability of CtIP to promote camptothecin resistance is impaired when Thr-847 is mutated to an unphosphorylatable Ala residue but not when it is altered to a phospho-mimicking Glu residue. Furthermore, the camptothecin sensitivity phenotype imparted by the CtIP T847A mutation might reflect impaired processing of camptothecin-induced DSBs into ssDNA.
###end p 21
###begin p 22
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 56 9 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Functional effects of mutating Thr-847 of CtIP.</bold>
###xml 56 57 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 122 128 122 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrows</italic>
###xml 195 228 195 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. thaliana, Arabidopsis thaliana</italic>
###xml 230 264 230 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans, Caenorhabditis elegans</italic>
###xml 266 299 266 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. nodorum, Phaeosphaeria nodorum</italic>
###xml 301 333 301 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. globosum, Chaetomium globosum</italic>
###xml 335 363 335 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N. crassa, Neurospora crassa</italic>
###xml 365 403 365 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans, Cryptococcus neoformans</italic>
###xml 405 439 405 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. lipolytica, Yarrowia lipolytica</italic>
###xml 441 472 441 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. gossypii, Ashbya gossypii. B</italic>
###xml 553 557 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 569 574 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 612 618 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siCtIP</italic>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 899 900 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1067 1069 1063 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1253 1259 1249 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 1328 1331 1324 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 9 1333 9 1329 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="23"><bold>Functional effects of mutating Thr-847 of CtIP.</bold><italic>A</italic>, alignment of the region conserved among Sae2/CtIP orthologues. <italic>Arrows</italic> show the position of the conserved CtIP Thr-847 and Sae2 Ser-267. <italic>A. thaliana, Arabidopsis thaliana</italic>; <italic>C. elegans, Caenorhabditis elegans</italic>; <italic>P. nodorum, Phaeosphaeria nodorum</italic>; <italic>C. globosum, Chaetomium globosum</italic>; <italic>N. crassa, Neurospora crassa</italic>; <italic>C. neoformans, Cryptococcus neoformans</italic>; <italic>Y. lipolytica, Yarrowia lipolytica</italic>; <italic>A. gossypii, Ashbya gossypii. B</italic>, expression levels of GFP-CtIP derivatives in stably transfected clones before (<italic>left</italic>) or after (<italic>right</italic>) siRNA depletion of endogenous CtIP (<italic>siCtIP</italic>). <italic>C</italic>, representative confocal microscope images of cells expressing wild-type or T847A CtIP variants after immunostaining with a phospho-specific antibody raised against phosphorylated Thr-847. Cells were incubated in the presence of the CDK inhibitor roscovitine where indicated. <italic>D</italic>, a GST-fused wild-type or T847A mutant CtIP C-terminal fragment (residues 750-897) was affinity-purified with glutathione-Sepharose 4B and then incubated with [&#947;-<sup>32</sup>P]ATP in the presence or absence of recombinant CDK2/cyclin A, separated by 10% SDS-PAGE, and transferred to nitrocellulose membrane. Proteins were detected with an anti-GST antibody (<italic>bottom</italic>), and phosphorylation was visualized by autoradiography (CDK assay; <italic>top</italic>).</p>
###xml 9 1333 9 1329 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="23"><bold>Functional effects of mutating Thr-847 of CtIP.</bold><italic>A</italic>, alignment of the region conserved among Sae2/CtIP orthologues. <italic>Arrows</italic> show the position of the conserved CtIP Thr-847 and Sae2 Ser-267. <italic>A. thaliana, Arabidopsis thaliana</italic>; <italic>C. elegans, Caenorhabditis elegans</italic>; <italic>P. nodorum, Phaeosphaeria nodorum</italic>; <italic>C. globosum, Chaetomium globosum</italic>; <italic>N. crassa, Neurospora crassa</italic>; <italic>C. neoformans, Cryptococcus neoformans</italic>; <italic>Y. lipolytica, Yarrowia lipolytica</italic>; <italic>A. gossypii, Ashbya gossypii. B</italic>, expression levels of GFP-CtIP derivatives in stably transfected clones before (<italic>left</italic>) or after (<italic>right</italic>) siRNA depletion of endogenous CtIP (<italic>siCtIP</italic>). <italic>C</italic>, representative confocal microscope images of cells expressing wild-type or T847A CtIP variants after immunostaining with a phospho-specific antibody raised against phosphorylated Thr-847. Cells were incubated in the presence of the CDK inhibitor roscovitine where indicated. <italic>D</italic>, a GST-fused wild-type or T847A mutant CtIP C-terminal fragment (residues 750-897) was affinity-purified with glutathione-Sepharose 4B and then incubated with [&#947;-<sup>32</sup>P]ATP in the presence or absence of recombinant CDK2/cyclin A, separated by 10% SDS-PAGE, and transferred to nitrocellulose membrane. Proteins were detected with an anti-GST antibody (<italic>bottom</italic>), and phosphorylation was visualized by autoradiography (CDK assay; <italic>top</italic>).</p></caption>
###xml 1333 1333 1329 1329 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972190001"/>
###xml 0 1333 0 1329 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="23"><bold>Functional effects of mutating Thr-847 of CtIP.</bold><italic>A</italic>, alignment of the region conserved among Sae2/CtIP orthologues. <italic>Arrows</italic> show the position of the conserved CtIP Thr-847 and Sae2 Ser-267. <italic>A. thaliana, Arabidopsis thaliana</italic>; <italic>C. elegans, Caenorhabditis elegans</italic>; <italic>P. nodorum, Phaeosphaeria nodorum</italic>; <italic>C. globosum, Chaetomium globosum</italic>; <italic>N. crassa, Neurospora crassa</italic>; <italic>C. neoformans, Cryptococcus neoformans</italic>; <italic>Y. lipolytica, Yarrowia lipolytica</italic>; <italic>A. gossypii, Ashbya gossypii. B</italic>, expression levels of GFP-CtIP derivatives in stably transfected clones before (<italic>left</italic>) or after (<italic>right</italic>) siRNA depletion of endogenous CtIP (<italic>siCtIP</italic>). <italic>C</italic>, representative confocal microscope images of cells expressing wild-type or T847A CtIP variants after immunostaining with a phospho-specific antibody raised against phosphorylated Thr-847. Cells were incubated in the presence of the CDK inhibitor roscovitine where indicated. <italic>D</italic>, a GST-fused wild-type or T847A mutant CtIP C-terminal fragment (residues 750-897) was affinity-purified with glutathione-Sepharose 4B and then incubated with [&#947;-<sup>32</sup>P]ATP in the presence or absence of recombinant CDK2/cyclin A, separated by 10% SDS-PAGE, and transferred to nitrocellulose membrane. Proteins were detected with an anti-GST antibody (<italic>bottom</italic>), and phosphorylation was visualized by autoradiography (CDK assay; <italic>top</italic>).</p></caption><graphic xlink:href="zbc0190972190001"/></fig>
###xml 195 206 <span type="species:ncbi:3702">A. thaliana</span>
###xml 208 228 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 230 240 <span type="species:ncbi:6239">C. elegans</span>
###xml 242 264 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 266 276 <span type="species:ncbi:13684">P. nodorum</span>
###xml 278 299 <span type="species:ncbi:13684">Phaeosphaeria nodorum</span>
###xml 301 312 <span type="species:ncbi:38033">C. globosum</span>
###xml 314 333 <span type="species:ncbi:38033">Chaetomium globosum</span>
###xml 335 344 <span type="species:ncbi:5141">N. crassa</span>
###xml 346 363 <span type="species:ncbi:5141">Neurospora crassa</span>
###xml 365 378 <span type="species:ncbi:5207">C. neoformans</span>
###xml 380 392 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 380 403 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 405 418 <span type="species:ncbi:4952">Y. lipolytica</span>
###xml 420 439 <span type="species:ncbi:4952">Yarrowia lipolytica</span>
###xml 441 452 <span type="species:ncbi:33169">A. gossypii</span>
###xml 454 469 <span type="species:ncbi:33169">Ashbya gossypii</span>
FIGURE 1.Functional effects of mutating Thr-847 of CtIP.A, alignment of the region conserved among Sae2/CtIP orthologues. Arrows show the position of the conserved CtIP Thr-847 and Sae2 Ser-267. A. thaliana, Arabidopsis thaliana; C. elegans, Caenorhabditis elegans; P. nodorum, Phaeosphaeria nodorum; C. globosum, Chaetomium globosum; N. crassa, Neurospora crassa; C. neoformans, Cryptococcus neoformans; Y. lipolytica, Yarrowia lipolytica; A. gossypii, Ashbya gossypii. B, expression levels of GFP-CtIP derivatives in stably transfected clones before (left) or after (right) siRNA depletion of endogenous CtIP (siCtIP). C, representative confocal microscope images of cells expressing wild-type or T847A CtIP variants after immunostaining with a phospho-specific antibody raised against phosphorylated Thr-847. Cells were incubated in the presence of the CDK inhibitor roscovitine where indicated. D, a GST-fused wild-type or T847A mutant CtIP C-terminal fragment (residues 750-897) was affinity-purified with glutathione-Sepharose 4B and then incubated with [gamma-32P]ATP in the presence or absence of recombinant CDK2/cyclin A, separated by 10% SDS-PAGE, and transferred to nitrocellulose membrane. Proteins were detected with an anti-GST antibody (bottom), and phosphorylation was visualized by autoradiography (CDK assay; top).
###end p 22
###begin p 23
###xml 0 47 0 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Functional effects of mutating Thr-847 of CtIP.</bold>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrows</italic>
###xml 186 219 186 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. thaliana, Arabidopsis thaliana</italic>
###xml 221 255 221 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans, Caenorhabditis elegans</italic>
###xml 257 290 257 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. nodorum, Phaeosphaeria nodorum</italic>
###xml 292 324 292 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. globosum, Chaetomium globosum</italic>
###xml 326 354 326 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N. crassa, Neurospora crassa</italic>
###xml 356 394 356 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans, Cryptococcus neoformans</italic>
###xml 396 430 396 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y. lipolytica, Yarrowia lipolytica</italic>
###xml 432 463 432 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. gossypii, Ashbya gossypii. B</italic>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 560 565 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 603 609 603 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siCtIP</italic>
###xml 612 613 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 890 891 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1058 1060 1054 1056 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 1244 1250 1240 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom</italic>
###xml 1319 1322 1315 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 186 197 <span type="species:ncbi:3702">A. thaliana</span>
###xml 199 219 <span type="species:ncbi:3702">Arabidopsis thaliana</span>
###xml 221 231 <span type="species:ncbi:6239">C. elegans</span>
###xml 233 255 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 257 267 <span type="species:ncbi:13684">P. nodorum</span>
###xml 269 290 <span type="species:ncbi:13684">Phaeosphaeria nodorum</span>
###xml 292 303 <span type="species:ncbi:38033">C. globosum</span>
###xml 305 324 <span type="species:ncbi:38033">Chaetomium globosum</span>
###xml 326 335 <span type="species:ncbi:5141">N. crassa</span>
###xml 337 354 <span type="species:ncbi:5141">Neurospora crassa</span>
###xml 356 369 <span type="species:ncbi:5207">C. neoformans</span>
###xml 371 383 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 371 394 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 396 409 <span type="species:ncbi:4952">Y. lipolytica</span>
###xml 411 430 <span type="species:ncbi:4952">Yarrowia lipolytica</span>
###xml 432 443 <span type="species:ncbi:33169">A. gossypii</span>
###xml 445 460 <span type="species:ncbi:33169">Ashbya gossypii</span>
Functional effects of mutating Thr-847 of CtIP.A, alignment of the region conserved among Sae2/CtIP orthologues. Arrows show the position of the conserved CtIP Thr-847 and Sae2 Ser-267. A. thaliana, Arabidopsis thaliana; C. elegans, Caenorhabditis elegans; P. nodorum, Phaeosphaeria nodorum; C. globosum, Chaetomium globosum; N. crassa, Neurospora crassa; C. neoformans, Cryptococcus neoformans; Y. lipolytica, Yarrowia lipolytica; A. gossypii, Ashbya gossypii. B, expression levels of GFP-CtIP derivatives in stably transfected clones before (left) or after (right) siRNA depletion of endogenous CtIP (siCtIP). C, representative confocal microscope images of cells expressing wild-type or T847A CtIP variants after immunostaining with a phospho-specific antibody raised against phosphorylated Thr-847. Cells were incubated in the presence of the CDK inhibitor roscovitine where indicated. D, a GST-fused wild-type or T847A mutant CtIP C-terminal fragment (residues 750-897) was affinity-purified with glutathione-Sepharose 4B and then incubated with [gamma-32P]ATP in the presence or absence of recombinant CDK2/cyclin A, separated by 10% SDS-PAGE, and transferred to nitrocellulose membrane. Proteins were detected with an anti-GST antibody (bottom), and phosphorylation was visualized by autoradiography (CDK assay; top).
###end p 23
###begin p 24
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 92 9 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of CtIP mutations on cellular responses to camptothecin-induced DNA damage.</bold>
###xml 92 93 92 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 232 242 232 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 446 447 437 438 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 496 506 487 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 9 598 9 589 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25"><bold>Effects of CtIP mutations on cellular responses to camptothecin-induced DNA damage.</bold><italic>A</italic>, cell survival after exposing cells expressing GFP-CtIP fusions to the indicated doses of camptothecin; averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. <italic>B</italic>, quantification of &#947;H2AX and RPA foci-positive cells and &#947;H2AX focus-positive cells for the indicated CtIP variants after 1 h of treatment with 1 &#956;<sc>m</sc> camptothecin. Averages and standard deviations (<italic>error bars</italic>) of four independent experiments are shown. At least 200 cells were counted per experiment.</p>
###xml 9 598 9 589 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25"><bold>Effects of CtIP mutations on cellular responses to camptothecin-induced DNA damage.</bold><italic>A</italic>, cell survival after exposing cells expressing GFP-CtIP fusions to the indicated doses of camptothecin; averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. <italic>B</italic>, quantification of &#947;H2AX and RPA foci-positive cells and &#947;H2AX focus-positive cells for the indicated CtIP variants after 1 h of treatment with 1 &#956;<sc>m</sc> camptothecin. Averages and standard deviations (<italic>error bars</italic>) of four independent experiments are shown. At least 200 cells were counted per experiment.</p></caption>
###xml 598 598 589 589 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972190002"/>
###xml 0 598 0 589 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="25"><bold>Effects of CtIP mutations on cellular responses to camptothecin-induced DNA damage.</bold><italic>A</italic>, cell survival after exposing cells expressing GFP-CtIP fusions to the indicated doses of camptothecin; averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. <italic>B</italic>, quantification of &#947;H2AX and RPA foci-positive cells and &#947;H2AX focus-positive cells for the indicated CtIP variants after 1 h of treatment with 1 &#956;<sc>m</sc> camptothecin. Averages and standard deviations (<italic>error bars</italic>) of four independent experiments are shown. At least 200 cells were counted per experiment.</p></caption><graphic xlink:href="zbc0190972190002"/></fig>
FIGURE 2.Effects of CtIP mutations on cellular responses to camptothecin-induced DNA damage.A, cell survival after exposing cells expressing GFP-CtIP fusions to the indicated doses of camptothecin; averages and standard deviations (error bars) of three independent experiments are shown. B, quantification of gammaH2AX and RPA foci-positive cells and gammaH2AX focus-positive cells for the indicated CtIP variants after 1 h of treatment with 1 mum camptothecin. Averages and standard deviations (error bars) of four independent experiments are shown. At least 200 cells were counted per experiment.
###end p 24
###begin p 25
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of CtIP mutations on cellular responses to camptothecin-induced DNA damage.</bold>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 223 233 223 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 437 438 428 429 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 487 497 478 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
Effects of CtIP mutations on cellular responses to camptothecin-induced DNA damage.A, cell survival after exposing cells expressing GFP-CtIP fusions to the indicated doses of camptothecin; averages and standard deviations (error bars) of three independent experiments are shown. B, quantification of gammaH2AX and RPA foci-positive cells and gammaH2AX focus-positive cells for the indicated CtIP variants after 1 h of treatment with 1 mum camptothecin. Averages and standard deviations (error bars) of four independent experiments are shown. At least 200 cells were counted per experiment.
###end p 25
###begin p 26
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 86 9 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of CtIP mutations on recruitment of proteins to laser-induced damage.</bold>
###xml 211 218 211 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">magenta</italic>
###xml 249 252 245 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 295 296 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 334 335 330 331 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 353 358 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">empty</italic>
###xml 363 376 359 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled arrows</italic>
###xml 9 391 9 387 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27"><bold>Effects of CtIP mutations on recruitment of proteins to laser-induced damage.</bold> Representative images of cells expressing GFP-CtIP variants after laser damage are shown. Cells were immunostained for RPA (<italic>magenta</italic>) and &#947;H2AX plus cyclin A (<italic>red</italic>). Damaged cells not expressing cyclin A (G<sub>1</sub>) and cells positive for cyclin A (S/G<sub>2</sub>) are marked with <italic>empty</italic> and <italic>filled arrows</italic>, respectively.</p>
###xml 9 391 9 387 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="27"><bold>Effects of CtIP mutations on recruitment of proteins to laser-induced damage.</bold> Representative images of cells expressing GFP-CtIP variants after laser damage are shown. Cells were immunostained for RPA (<italic>magenta</italic>) and &#947;H2AX plus cyclin A (<italic>red</italic>). Damaged cells not expressing cyclin A (G<sub>1</sub>) and cells positive for cyclin A (S/G<sub>2</sub>) are marked with <italic>empty</italic> and <italic>filled arrows</italic>, respectively.</p></caption>
###xml 391 391 387 387 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972190003"/>
###xml 0 391 0 387 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="27"><bold>Effects of CtIP mutations on recruitment of proteins to laser-induced damage.</bold> Representative images of cells expressing GFP-CtIP variants after laser damage are shown. Cells were immunostained for RPA (<italic>magenta</italic>) and &#947;H2AX plus cyclin A (<italic>red</italic>). Damaged cells not expressing cyclin A (G<sub>1</sub>) and cells positive for cyclin A (S/G<sub>2</sub>) are marked with <italic>empty</italic> and <italic>filled arrows</italic>, respectively.</p></caption><graphic xlink:href="zbc0190972190003"/></fig>
FIGURE 3.Effects of CtIP mutations on recruitment of proteins to laser-induced damage. Representative images of cells expressing GFP-CtIP variants after laser damage are shown. Cells were immunostained for RPA (magenta) and gammaH2AX plus cyclin A (red). Damaged cells not expressing cyclin A (G1) and cells positive for cyclin A (S/G2) are marked with empty and filled arrows, respectively.
###end p 26
###begin p 27
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of CtIP mutations on recruitment of proteins to laser-induced damage.</bold>
###xml 202 209 202 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">magenta</italic>
###xml 240 243 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 286 287 282 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 325 326 321 322 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 344 349 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">empty</italic>
###xml 354 367 350 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled arrows</italic>
Effects of CtIP mutations on recruitment of proteins to laser-induced damage. Representative images of cells expressing GFP-CtIP variants after laser damage are shown. Cells were immunostained for RPA (magenta) and gammaH2AX plus cyclin A (red). Damaged cells not expressing cyclin A (G1) and cells positive for cyclin A (S/G2) are marked with empty and filled arrows, respectively.
###end p 27
###begin p 28
###xml 0 63 0 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtIP Mutations Affect Recruitment of CtIP and RPA to DNA Damage</italic>
###xml 238 239 238 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1341 1342 1337 1338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1357 1358 1353 1354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1580 1583 1572 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A-D</italic>
###xml 1572 1583 1564 1575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A-D</italic></xref>
###xml 1779 1781 1767 1769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1843 1844 1831 1832 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1893 1894 1881 1882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1887 1894 1875 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>E</italic></xref>
###xml 1896 1909 1884 1897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled arrows</italic>
###xml 1941 1942 1929 1930 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1950 1961 1938 1949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open arrows</italic>
###xml 2118 2119 2106 2107 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2166 2167 2154 2155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2205 2206 2193 2194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 2211 2212 2199 2200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">J</italic>
###xml 2197 2212 2185 2200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>I</italic> and <italic>J</italic></xref>
###xml 2391 2392 2379 2380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2400 2401 2388 2389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 2394 2401 2382 2389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>G</italic></xref>
###xml 2403 2416 2391 2404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled arrows</italic>
###xml 2494 2495 2482 2483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2521 2522 2509 2510 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2564 2575 2552 2563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open arrows</italic>
###xml 2736 2737 2724 2725 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2879 2880 2867 2868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 2885 2886 2873 2874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 2871 2886 2859 2874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>K</italic> and <italic>I</italic></xref>
###xml 2974 2975 2962 2963 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 3011 3012 2999 3000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 3005 3012 2993 3000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>K</italic></xref>
###xml 3014 3025 3002 3013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open arrows</italic>
###xml 3073 3074 3061 3062 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 3082 3095 3070 3083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled arrows</italic>
CtIP Mutations Affect Recruitment of CtIP and RPA to DNA Damage-CtIP modulates responses to DNA damage in a cell cycle-dependent manner and is only effectively recruited to sites of laser-induced damage in cyclin A-positive cells (S and G2 cells), when RPA tracts are also formed (11). As CtIP depletion impairs ssDNA formation after camptothecin treatment, this suggests that assessment of camptothecin-induced RPA focus formation would be an effective way to test the effects of mutating CtIP Thr-847. However, this approach has several limitations. First, camptothecin primarily yields DSBs only in S-phase; second, CtIP recruitment into discernible foci is difficult to observe after camptothecin treatment (11); and third, to observe RPA recruitment to sites of DNA damage, cellular preextraction is required, which impedes co-staining for soluble cell cycle markers such as cyclins. To overcome these problems, we used laser DNA-damaging microirradiation. Thus, we laser-irradiated the previously described cell clones stably expressing wild-type or mutated CtIP derivatives after they had been siRNA-depleted of endogenous CtIP. Next, we assessed the appearance of DNA damage tracts by immunofluorescence with antibodies against RPA (to detect RPA-coated ssDNA), gammaH2AX (to detect damaged chromatin), and cyclin A (to distinguish G1 cells from S/G2 cells. Due to limitations in the number of channels available in the microscope and in the number of non-cross-reacting secondary antibodies, gammaH2AX and cyclin A were analyzed in the same channel). As shown in Fig. 3, A-D, laser-induced gammaH2AX tracts were clearly evident in all irradiated cells, irrespective of whether or not they displayed pannuclear cyclin A staining. By contrast, and as reported previously (11), wild-type GFP-CtIP was recruited to damage sites in all S/G2 cells that stained positive for cyclin A (Fig. 3E, filled arrows) but not in cyclin A-negative G1 cells (open arrows). Notably, although a similar recruitment kinetics was observed for the CtIP-T847A mutant (supplemental Fig. 2), RPA recruitment was readily observed in S/G2 cells expressing wild-type CtIP but not in S/G2 cells expressing CtIP-T847A (Fig. 3, I and J), implying that Thr-847 phosphorylation regulates the ability of CtIP to promote resection. In line with this, whereas CtIP-T847E was effectively recruited to damage sites in S/G2 (Fig. 3G, filled arrows; supplemental Fig. 2 for kinetics), it was also recruited to some degree in G1 cells (more than 80% of G1 cells showed weak but visible GFP lines; open arrows). This suggests that mimicking constitutive phosphorylation enhances CtIP activity and raises the possibility that this might allow some CtIP function even in G1 cells. Indeed, cells expressing CtIP-T847E generally displayed more pronounced RPA recruitment than cells expressing wild-type CtIP (Fig. 3, K and I, respectively), and furthermore, weak RPA recruitment was evident in more than 90% of G1 cells expressing CtIP-T847E (Fig. 3K, open arrows), although this was less pronounced than in S/G2 cells (filled arrows). These findings thus suggest that CtIP Thr-847 controls resection during the cell cycle but imply that other CDK-mediated phosphorylations are also needed for optimal resection to occur.
###end p 28
###begin p 29
###xml 0 59 0 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CtIP-T847E Promotes Resection Even Following CDK Inhibition</italic>
###xml 318 324 318 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 663 664 663 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1368 1369 1364 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1362 1369 1358 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 2027 2028 2023 2024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2021 2028 2017 2024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 2189 2190 2185 2186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 2195 2196 2191 2192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2181 2196 2177 2192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>B</italic> and <italic>C</italic></xref>
CtIP-T847E Promotes Resection Even Following CDK Inhibition-Although the above data suggest that mimicking constitutive phosphorylation of CtIP Thr-847 can partially overcome the CDK requirement for DNA DSB processing, it was formally possible that the cyclin A-negative CtIP-T847E cells displaying RPA recruitment in Fig. 3 were in early S-phase, when CDK was already active, but cyclin A levels were too weak for detection. To address this possibility, we siRNA-depleted endogenous CtIP from cells stably expressing siRNA-resistant GFP-CtIP variants and then treated them with DMSO (negative control) or with the CDK inhibitor, roscovitine. (Supplemental Fig. 1B shows that the fluorescence-activated cell sorter distributions of DMSO- and roscovitine-treated samples were similar, presumably reflecting inhibition of cell cycle transitions by roscovitine.) Next, we treated the cells with X-rays. We chose x-ray treatment because it generates DSBs in all cell cycle phases and allowed us to damage a larger number of cells than we could with laser microirradiation. Subsequently, we assessed cells for DSB formation (gammaH2AX foci) and ssDNA production (RPA foci). In line with our previous results, DMSO-treated cells expressing wild-type GFP-CtIP or GFP-CtIP-T847E effectively formed RPA foci, whereas cells expressing GFP-CtIP T847A or GFP alone did not (Fig. 4A). Similar results were obtained when we detected ssDNA with an anti-bromodeoxyuridine antibody labeling method (supplemental Fig. 3), indicating that CtIP Thr-847 indeed controls ssDNA formation. Taken together with our other data, these findings therefore indicate that CtIP phosphorylation on Thr-847 controls ssDNA formation and RPA recruitment to sites of damaged DNA induced by camptothecin, laser microirradiation, or X-rays. Furthermore, we found that although roscovitine severely curtailed RPA focus formation following exposure to IR in cells expressing wild-type CtIP, it did not prevent RPA focus formation in cells expressing CtIP-T847E (Fig. 4A). Nevertheless, careful comparisons revealed that roscovitine treatment did reduce the intensity and number of RPA foci in cells expressing CtIP-T847E (Fig. 4, B and C), showing that although CtIP-T847E permits resection even after CDK inhibition, this resection is less extensive than in the presence of CDK activity.
###end p 29
###begin p 30
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 46 9 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CtIP mutations affect DSB processing.</bold>
###xml 46 47 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 115 116 114 115 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 130 135 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosc.</italic>
###xml 272 282 267 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 376 377 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 421 425 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. C</italic>
###xml 566 576 561 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 599 600 594 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 744 748 739 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 753 758 748 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 9 858 9 853 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31"><bold>CtIP mutations affect DSB processing.</bold><italic>A</italic>, cells expressing CtIP variants were treated with DMSO (-) or 25 &#956;<sc>m</sc> roscovitine (<italic>Rosc.</italic>)(+) and then irradiated with 10 Gy of IR. One h later, cells were immunostained for RPA or &#947;H2AX. Averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. At least 200 cells were counted per experiment. <italic>B</italic>, representative images of cells treated in <italic>A. C</italic>, the number of RPA foci per cell in cells expressing the GFP-CtIP-T847E mutant in the presence or absence of the CDK inhibitor roscovitine. <italic>Error bars</italic>, standard deviations. <italic>D</italic>, an immunoblot of protein extracts, collected 1 h after irradiation (10 Gy), of cells expressing the indicated GFP-CtIP fusions. Panels to the <italic>left</italic> and <italic>right</italic> contain samples derived from cells treated in the absence or presence of roscovitine, respectively.</p>
###xml 9 858 9 853 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31"><bold>CtIP mutations affect DSB processing.</bold><italic>A</italic>, cells expressing CtIP variants were treated with DMSO (-) or 25 &#956;<sc>m</sc> roscovitine (<italic>Rosc.</italic>)(+) and then irradiated with 10 Gy of IR. One h later, cells were immunostained for RPA or &#947;H2AX. Averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. At least 200 cells were counted per experiment. <italic>B</italic>, representative images of cells treated in <italic>A. C</italic>, the number of RPA foci per cell in cells expressing the GFP-CtIP-T847E mutant in the presence or absence of the CDK inhibitor roscovitine. <italic>Error bars</italic>, standard deviations. <italic>D</italic>, an immunoblot of protein extracts, collected 1 h after irradiation (10 Gy), of cells expressing the indicated GFP-CtIP fusions. Panels to the <italic>left</italic> and <italic>right</italic> contain samples derived from cells treated in the absence or presence of roscovitine, respectively.</p></caption>
###xml 858 858 853 853 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972190004"/>
###xml 0 858 0 853 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="31"><bold>CtIP mutations affect DSB processing.</bold><italic>A</italic>, cells expressing CtIP variants were treated with DMSO (-) or 25 &#956;<sc>m</sc> roscovitine (<italic>Rosc.</italic>)(+) and then irradiated with 10 Gy of IR. One h later, cells were immunostained for RPA or &#947;H2AX. Averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. At least 200 cells were counted per experiment. <italic>B</italic>, representative images of cells treated in <italic>A. C</italic>, the number of RPA foci per cell in cells expressing the GFP-CtIP-T847E mutant in the presence or absence of the CDK inhibitor roscovitine. <italic>Error bars</italic>, standard deviations. <italic>D</italic>, an immunoblot of protein extracts, collected 1 h after irradiation (10 Gy), of cells expressing the indicated GFP-CtIP fusions. Panels to the <italic>left</italic> and <italic>right</italic> contain samples derived from cells treated in the absence or presence of roscovitine, respectively.</p></caption><graphic xlink:href="zbc0190972190004"/></fig>
FIGURE 4.CtIP mutations affect DSB processing.A, cells expressing CtIP variants were treated with DMSO (-) or 25 mum roscovitine (Rosc.)(+) and then irradiated with 10 Gy of IR. One h later, cells were immunostained for RPA or gammaH2AX. Averages and standard deviations (error bars) of three independent experiments are shown. At least 200 cells were counted per experiment. B, representative images of cells treated in A. C, the number of RPA foci per cell in cells expressing the GFP-CtIP-T847E mutant in the presence or absence of the CDK inhibitor roscovitine. Error bars, standard deviations. D, an immunoblot of protein extracts, collected 1 h after irradiation (10 Gy), of cells expressing the indicated GFP-CtIP fusions. Panels to the left and right contain samples derived from cells treated in the absence or presence of roscovitine, respectively.
###end p 30
###begin p 31
###xml 0 37 0 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CtIP mutations affect DSB processing.</bold>
###xml 37 38 37 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 106 107 105 106 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 121 126 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rosc.</italic>
###xml 263 273 258 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 367 368 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 412 416 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. C</italic>
###xml 557 567 552 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 590 591 585 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 735 739 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 744 749 739 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
CtIP mutations affect DSB processing.A, cells expressing CtIP variants were treated with DMSO (-) or 25 mum roscovitine (Rosc.)(+) and then irradiated with 10 Gy of IR. One h later, cells were immunostained for RPA or gammaH2AX. Averages and standard deviations (error bars) of three independent experiments are shown. At least 200 cells were counted per experiment. B, representative images of cells treated in A. C, the number of RPA foci per cell in cells expressing the GFP-CtIP-T847E mutant in the presence or absence of the CDK inhibitor roscovitine. Error bars, standard deviations. D, an immunoblot of protein extracts, collected 1 h after irradiation (10 Gy), of cells expressing the indicated GFP-CtIP fusions. Panels to the left and right contain samples derived from cells treated in the absence or presence of roscovitine, respectively.
###end p 31
###begin p 32
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 839 841 839 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 1092 1094 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 1293 1295 1293 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1297 1299 1297 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 1671 1672 1671 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1665 1672 1665 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 1830 1831 1830 1831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1824 1831 1824 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 1833 1844 1833 1844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panels</italic>
###xml 2065 2066 2065 2066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 2059 2066 2059 2066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 2068 2080 2068 2080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panels</italic>
Although the study of focus formation by microscopy is used commonly in the DNA damage-response field, it has some limitations. On the one hand, foci are complex structures in which several types of damage can coexist and, therefore, different DNA repair pathways can operate at the same locations. In addition, to be visible, the foci must contain thousands of protein molecules, meaning that more subtle events close to the DNA lesions might be missed. To complement our data with focus formation, we therefore prepared extracts from DNA-damaged or control cells and then analyzed them by Western immunoblotting for phosphorylation on Ser-4 and Ser-8 of the 32-kDa subunit of RPA (RPA32). These modifications are generated after different types of DNA damage (15, 16) by mechanisms that involve the DNA-dependent protein kinase (DNA-PK (17)). Although the precise roles for these RPA32 phosphorylations are not known, because they affect the affinity of RPA toward both ssDNA and double-stranded DNA (18) and increase the interaction of RPA with the recombination proteins Rad51 and Rad52 (19), it has been proposed that RPA Ser-4/8 phosphorylation facilitates RPA eviction and homologous recombination. Importantly, as RPA Ser-4/8 phosphorylation appears to only occur after DNA resection (11, 17), the detection of this modified form of RPA is a very sensitive readout of DNA end processing. Notably, we readily detected RPA32 Ser-4/8 phosphorylation, both by using phospho-specific antisera and by reduced mobility of the protein on SDS-PAGE, in irradiated cells expressing wild-type CtIP or CtIP-T847E but not in cells expressing GFP alone or GFP-CtIP T847A (Fig. 4D). Furthermore, we found that RPA32 Ser-4/8 phosphorylation was slightly higher in cells expressing CtIP-T847E than in cells expressing wild-type CtIP (Fig. 4D, left panels). Moreover, although roscovitine abolished RPA Ser-4/8 phosphorylation in cells expressing wild-type CtIP, residual RPA phosphorylation was still evident after roscovitine treatment of cells expressing CtIP-T847E (Fig. 4D, right panels). These data therefore provide strong support for CtIP Thr-847 phosphorylation playing a key role in mediating cell cycle control of DSB resection and RPA recruitment.
###end p 32
###begin p 33
###xml 0 52 0 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mutation of CtIP Thr-847 Influences Genome Stability</italic>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 689 690 689 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1012 1013 1012 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1006 1013 1006 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1131 1132 1131 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1125 1132 1125 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 1365 1367 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1369 1371 1369 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 1392 1393 1392 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1386 1393 1386 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 195 200 <span type="species:ncbi:4932">yeast</span>
###xml 744 749 <span type="species:ncbi:9606">human</span>
Mutation of CtIP Thr-847 Influences Genome Stability-Controlling DSB resection is thought to help ensure that the most appropriate DSB repair pathway is used at each cell cycle stage. In budding yeast, we have shown that this control depends on Sae2 Ser-267 phosphorylation by CDK and that defects in this mechanism lead to imbalances between NHEJ and HR, with the Sae2-S267A mutant favoring the former and Sae2-S267E the latter (8). Consequently, although Sae2-S267E mutant cells can repair S-phase-induced DSBs (such as are generated by camptothecin) that are mainly repaired by HR, they are mildly hypersensitive to IR due to deregulated ssDNA formation that appears to impair NHEJ in G1. To determine whether a similar phenomenon occurs in human cells, we siRNA-depleted endogenous CtIP from cells stably expressing siRNA-resistant wild-type or Thr-847 mutated GFP-CtIP derivatives and then assessed cell survival after IR. Strikingly, and in contrast to the survival data after camptothecin exposure (Fig. 2A), both CtIP T847A and CtIP-T847E mutant cells were mildly hypersensitive to IR, similar to cells lacking CtIP (Fig. 5A). To test the idea that hypersensitivity of CtIP-T847E cells might reflect impaired NHEJ, we assessed the ability of these and the other cells to randomly integrate plasmid DNA into their genome, a process that is mediated by NHEJ (14, 20). As shown in Fig. 5B, CtIP-T847E cells but not CtIP T847A or CtIP-depleted cells were mildly but significantly defective in this process, thus suggesting that the IR hypersensitivity of CtIP-T847E cells at least partly reflected impaired NHEJ.
###end p 33
###begin p 34
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 74 9 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of CtIP mutations on DNA repair and chromosome integrity.</bold>
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 191 201 191 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 247 248 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 469 479 469 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 525 526 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 733 743 733 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 766 767 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 826 827 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 9 828 9 828 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35"><bold>Effects of CtIP mutations on DNA repair and chromosome integrity.</bold><italic>A</italic>, the survival of U2OS cells expressing GFP-CtIP fusions after treatment with IR. Averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. <italic>B</italic>, the effects of CtIP mutations on NHEJ efficiency as measured by random plasmid integration. Frequencies of integration were normalized to the values of wild-type GFP-CtIP, set as 100%. Averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. <italic>C</italic>, the percentage of mitoses showing 1, 2, 3, 4, or 5 GCRs in cells expressing GFP-CtIP variants either untreated (<italic>left</italic>) or treated with 2 Gy of IR (<italic>right</italic>). At least 100 mitoses were analyzed per experiment. <italic>Error bars</italic>, standard deviations. <italic>D</italic>, the percentage of each GCR type in the cells analyzed in <italic>C</italic>.</p>
###xml 9 828 9 828 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35"><bold>Effects of CtIP mutations on DNA repair and chromosome integrity.</bold><italic>A</italic>, the survival of U2OS cells expressing GFP-CtIP fusions after treatment with IR. Averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. <italic>B</italic>, the effects of CtIP mutations on NHEJ efficiency as measured by random plasmid integration. Frequencies of integration were normalized to the values of wild-type GFP-CtIP, set as 100%. Averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. <italic>C</italic>, the percentage of mitoses showing 1, 2, 3, 4, or 5 GCRs in cells expressing GFP-CtIP variants either untreated (<italic>left</italic>) or treated with 2 Gy of IR (<italic>right</italic>). At least 100 mitoses were analyzed per experiment. <italic>Error bars</italic>, standard deviations. <italic>D</italic>, the percentage of each GCR type in the cells analyzed in <italic>C</italic>.</p></caption>
###xml 828 828 828 828 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972190005"/>
###xml 0 828 0 828 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="35"><bold>Effects of CtIP mutations on DNA repair and chromosome integrity.</bold><italic>A</italic>, the survival of U2OS cells expressing GFP-CtIP fusions after treatment with IR. Averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. <italic>B</italic>, the effects of CtIP mutations on NHEJ efficiency as measured by random plasmid integration. Frequencies of integration were normalized to the values of wild-type GFP-CtIP, set as 100%. Averages and standard deviations (<italic>error bars</italic>) of three independent experiments are shown. <italic>C</italic>, the percentage of mitoses showing 1, 2, 3, 4, or 5 GCRs in cells expressing GFP-CtIP variants either untreated (<italic>left</italic>) or treated with 2 Gy of IR (<italic>right</italic>). At least 100 mitoses were analyzed per experiment. <italic>Error bars</italic>, standard deviations. <italic>D</italic>, the percentage of each GCR type in the cells analyzed in <italic>C</italic>.</p></caption><graphic xlink:href="zbc0190972190005"/></fig>
FIGURE 5.Effects of CtIP mutations on DNA repair and chromosome integrity.A, the survival of U2OS cells expressing GFP-CtIP fusions after treatment with IR. Averages and standard deviations (error bars) of three independent experiments are shown. B, the effects of CtIP mutations on NHEJ efficiency as measured by random plasmid integration. Frequencies of integration were normalized to the values of wild-type GFP-CtIP, set as 100%. Averages and standard deviations (error bars) of three independent experiments are shown. C, the percentage of mitoses showing 1, 2, 3, 4, or 5 GCRs in cells expressing GFP-CtIP variants either untreated (left) or treated with 2 Gy of IR (right). At least 100 mitoses were analyzed per experiment. Error bars, standard deviations. D, the percentage of each GCR type in the cells analyzed in C.
###end p 34
###begin p 35
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of CtIP mutations on DNA repair and chromosome integrity.</bold>
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 182 192 182 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 460 470 460 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 665 670 665 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 724 734 724 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Error bars</italic>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 817 818 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
Effects of CtIP mutations on DNA repair and chromosome integrity.A, the survival of U2OS cells expressing GFP-CtIP fusions after treatment with IR. Averages and standard deviations (error bars) of three independent experiments are shown. B, the effects of CtIP mutations on NHEJ efficiency as measured by random plasmid integration. Frequencies of integration were normalized to the values of wild-type GFP-CtIP, set as 100%. Averages and standard deviations (error bars) of three independent experiments are shown. C, the percentage of mitoses showing 1, 2, 3, 4, or 5 GCRs in cells expressing GFP-CtIP variants either untreated (left) or treated with 2 Gy of IR (right). At least 100 mitoses were analyzed per experiment. Error bars, standard deviations. D, the percentage of each GCR type in the cells analyzed in C.
###end p 35
###begin p 36
###xml 316 317 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 310 317 310 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 633 634 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 627 634 627 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 812 813 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 806 813 806 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>D</italic></xref>
###xml 1710 1711 1710 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1704 1711 1704 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>D</italic></xref>
###xml 2000 2001 2000 2001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1994 2001 1994 2001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>D</italic></xref>
As a complementary approach to assess the effects of CtIP Thr-847 mutations, we examined the cell lines for radiation-induced GCRs. These studies revealed that 2 Gy of irradiation increased GCR formation in cells expressing wild-type CtIP, with around 50% of ensuing mitoses presenting at least one GCR event (Fig. 5C). Furthermore, somewhat more pronounced increases in GCR formation were observed in cells depleted of CtIP (GFP control) or expressing the CtIP mutants. Moreover, especially for cells expressing CtIP-T847A or the GFP control, there was an increase in the proportion of mitoses exhibiting multiple GCR events (Fig. 5C). In addition to determining overall GCR frequencies in the various cell lines, we also analyzed the data qualitatively by classifying GCRs into the following categories (Fig. 5D and supplemental Fig. 4): "two-end fusions" in which both arms of two chromosomes are fused; "one-end fusions" in which only one chromosomal arm of two chromosomes is fused (both one-end and two-end fusions probably result from NHEJ); "arms of different length" in which chromosome arms exhibit different lengths, probably due to insertions, deletions, or non-reciprocal exchanges; "chromatid breaks" in which one of the chromatids is broken but is held together by cohesion with its sister chromatid; and "complex GCRs" in which two or more chromosomes have suffered reciprocal exchanges, probably through aberrant HR. Strikingly, when compared with cells expressing wild-type CtIP, those expressing CtIP-T847E displayed an increased prevalence of complex GCRs and a reduction of fusions, which would be in agreement with increased aberrant HR and decreased NHEJ in the CtIP-T847E mutant (Fig. 5D). By contrast, cells expressing CtIP-T847A displayed the opposite pattern, exhibiting decreased complex GCRs and increased fusions, which would be consistent with increased NHEJ and reduced HR in this context (this pattern was similar to that of control cells expressing GFP alone; Fig. 5D). Collectively, these data therefore support a model in which CDK-mediated phosphorylation of CtIP Thr-847 controls DSB resection and thereby influences choice between the NHEJ and HR pathways of DSB repair.
###end p 36
###begin title 37
DISCUSSION
###end title 37
###begin p 38
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 345 350 <span type="species:ncbi:4932">yeast</span>
We have investigated the mechanisms by which human cells control DNA end resection during the cell cycle. Collectively, our data provide strong support for a model in which resection is controlled by CDK-mediated modification of CtIP on Thr-847 in a manner that is analogous to CDK targeting of a related consensus site (Ser-267) on the budding yeast CtIP counterpart, Sae2 (8). In light of these findings and the fact that analogous CDK target sites are found in almost all eukaryotic Sae2/CtIP counterparts, we speculate that this mode of resection control represents a widespread mechanism to regulate DSB repair during the cell cycle.
###end p 38
###begin p 39
###xml 0 74 0 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Modification of CtIP Thr-847 Modulates DNA Resection during the Cell Cycle</italic>
###xml 483 484 483 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 636 637 636 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 795 796 795 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 778 783 <span type="species:ncbi:4932">yeast</span>
Modification of CtIP Thr-847 Modulates DNA Resection during the Cell Cycle-Our results reveal that CtIP Thr-847 is needed for effective ssDNA generation, RPA recruitment, and RPA phosphorylation in response to camptothecin, laser-induced DNA damage, or ionizing radiation. Furthermore, we have established that mutating Thr-847 to Glu to mimic constitutive phosphorylation allows some resection in the absence of CDK activity, although this is not as effective as resection in S or G2 cells. Although it is possible that the T847E mutation does not fully mimic phosphorylation on this site, we think that this is unlikely because in S/G2 cells, the CtIP-T847E mutant promoted resection at least as well as wild-type CtIP. Instead, we favor a model (similar that to proposed for yeast Sae2 (Ref. 8)) in which CDK targeting of CtIP Thr-847 contributes to DSB resection but in which additional CDK targets, on other proteins or on CtIP itself, are needed for optimal resection. In this regard, we note that CtIP is CDK-phosphorylated on Ser-327 to promote interactions with BRCA1, a protein implicated in events occurring at resected DSBs (21). Furthermore, although we have generated phospho-specific antisera against peptides containing CtIP Thr-847 and they recognize CtIP only when CDKs are active, phospho-reactivity on Western blots was not abolished when CtIP was mutated on Thr-847 or was doubly mutated on Ser-327 and Thr-847 (data not shown). Although these results have unfortunately precluded the use of such antibodies to study Thr-847 phosphorylation by Western blot analyses, they nevertheless point to there being other CDK-dependent sites on CtIP that might potentially control its function.
###end p 39
###begin p 40
###xml 0 43 0 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Effects of Phosphorylation on CtIP Activity</italic>
###xml 268 276 268 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 486 496 486 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vice versa</italic>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 524 532 524 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 899 906 899 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 908 909 908 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 1002 1009 1002 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1014 1022 1014 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1466 1467 1466 1467 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1689 1691 1689 1691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 2447 2449 2447 2449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 2639 2652 2639 2652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 2915 2917 2915 2917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 3089 3090 3089 3090 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 3098 3099 3098 3099 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 3144 3146 3144 3146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 3148 3150 3148 3150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 154 159 <span type="species:ncbi:4932">yeast</span>
###xml 316 321 <span type="species:ncbi:9606">human</span>
###xml 549 554 <span type="species:ncbi:4932">yeast</span>
###xml 559 564 <span type="species:ncbi:9606">human</span>
###xml 2639 2652 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 2973 2978 <span type="species:ncbi:4932">yeast</span>
Effects of Phosphorylation on CtIP Activity-How phosphorylation of CtIP modulates resection is still not well understood. The CtIP counterpart in budding yeast, Sae2, has been shown to be an endonuclease that acts cooperatively with the Mre11-Rad50-Xrs2 (MRX) complex in vitro (22). Furthermore, combining CtIP with human Mre11 and Rad50 was shown to produce an endonuclease activity that neither component exhibited alone, although it is not yet known whether CtIP stimulates Mre11 or vice versa or both (11). Notably, the in vitro results for the yeast and human proteins were obtained in the absence of any known protein phosphorylation events, suggesting that phosphorylation of Sae2/CtIP is not absolutely required for its observed biochemical functions. Nevertheless, it is established that both CDK-dependent and checkpoint-dependent phosphorylations are required for activation of Sae2/CtIP in vivo (8, 21, 23). Although it is not yet clear why there are these apparent differences between the in vivo and in vitro data, it is possible that, within the cell, Sae2/MRX and CtIP/MRN (Mre11-Rad50-Nbs1) operate in a more stringent environment and/or do so in the presence of inhibitory proteins such that their resection functions are only exhibited upon activating phosphorylations. Alternatively, or in addition, it is possible that these modifications promote interactions with additional factors that might act as positive regulators of DNA resection in S/G2. In this regard, it is noteworthy that the interaction between CtIP and BRCA1 is controlled by CDK-mediated phosphorylation of CtIP Ser-327 and that such an interaction is required for CtIP recruitment to repair centers (21). Although this suggests that CDK-mediated Thr-847 phosphorylation might prime CtIP for further phosphorylation on Ser-327, thus allowing CtIP recruitment to repair foci, several lines of evidence argue against this. First, CtIP T847A is recruited to sites of DNA damage with similar kinetics to those of wild-type CtIP or the T847E mutant (supplemental Fig. 2). Second, we have found that the T847A mutant is still phosphorylated on Ser-327 and that it is still able to interact with BRCA1 (supplemental Fig. 5). Notably, we have also found that Thr-847 phosphorylation does not control the interaction between CtIP and MRN (supplemental Fig. 5) despite the fact that this interaction occurs through interactions that involve the CtIP C-terminal region (11). Hence, we propose that CDK activity is likely to control CtIP activity in at least two ways: one operating through Thr-847 that affects CtIP function by a mechanism that also operates in S. cerevisiae (via Sae2 Ser-267) and a second, higher eukaryote-specific mechanism that operates through BRCA1 interacting with CtIP phosphorylated on Ser-327. Notably, this latter mechanism seems to play a crucial role in bringing about CtIP recruitment to DNA damage sites (21), a mechanism that does not appear to exist in budding yeast, where it has been shown that Sae2 is always chromatin-bound and can localize to sites of DNA damage in both G1 and S/G2 independently of any factors tested so far (24, 25).
###end p 40
###begin p 41
###xml 0 66 0 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Deregulated DNA End Resection Leads to DNA Damage Hypersensitivity</italic>
###xml 279 280 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 515 516 515 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1451 1452 1451 1452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Deregulated DNA End Resection Leads to DNA Damage Hypersensitivity-Irrespective of the precise mechanisms at play, what seems clear is that CDK targeting of CtIP/Sae2 is used to restrict resection in phases of the cell cycle when NHEJ is favored and activate resection in S and G2, when HR is employed. Indeed, we have shown that lack of CtIP or an inability to activate CtIP by CDK-mediated phosphorylation on Thr-847 causes hypersensitivity toward DSB-generating agents, at least partly due to defective HR in S/G2. This is especially relevant when DNA DSBs are generated by agents such as camptothecin in S-phase, when HR is required for DNA replication restart. Conversely, our data imply that artificial activation of CtIP by mimicking constitutive phosphorylation of Thr-847 (which allows some DNA resection in the absence of CDK activity) can also result in deleterious consequences and DNA damage hypersensitivity. Therefore, the fine regulation of DNA resection during the cell cycle appears to be critical to ensure that the cell uses the DSB repair pathway most appropriate to its cell cycle status. Notably, we have found that both impaired resection and constitutive activation of resection (by blocking or mimicking constitutive phosphorylation of CtIP Thr-847, respectively) lead to increased sensitivity to DNA-damaging agents and increased formation of GCRs, although by differing mechanisms. Thus, although hampering resection in S/G2 leads to increased chromosomal fusions, probably due to increased NHEJ, hyperactivation of resection results in DSBs being processed at inappropriate times. Such aberrantly processed ends can then engage in futile HR cycles, resulting in complex GCRs and causing cell mortality, probably by mitotic catastrophe.
###end p 41
###begin p 42
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 500 501 500 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
It is noteworthy that not only CtIP mutations but also reduced CtIP levels and CtIP overexpression have been reported in various cancer cell lines (26-29) and that reduced CtIP levels lead to tumor formation in mouse models (30). Although these effects could reflect transcriptional functions for CtIP (31), it is tempting to speculate that they arise due to deregulated DSB resection, thus causing mutations and GCRs that foster tumor formation. For instance, overexpression of CtIP, especially in G1 when CtIP levels are normally low, might hyperactivate the DNA resection machinery, thus causing spurious HR or leading to large deletions at sites of NHEJ. On the other hand, CtIP-inactivating mutations or CtIP haplo-insufficiency could resemble what we have observed with CtIP T847A mutants, in which GCRs apparently arise due to reduced HR. If deregulated DSB resection is found in certain cancer cells, this raises the exciting prospect that such defects could be exploited by intelligent tailoring of existing DNA-damaging chemotherapies and/or by using compounds that selectively target specific DNA repair pathways.
###end p 42
###begin p 43
###xml 0 75 0 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Conserved Mechanisms for Regulating DSB Processing by CtIP/Sae2 Orthologues</italic>
###xml 242 255 242 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 759 767 759 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe</italic>
###xml 774 775 774 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 792 800 792 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe</italic>
###xml 1003 1004 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1023 1036 1023 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 1205 1206 1205 1206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1305 1318 1305 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 1328 1336 1328 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe</italic>
###xml 1547 1548 1547 1548 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1594 1596 1594 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 1598 1600 1598 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 1601 1603 1601 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 242 255 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 745 750 <span type="species:ncbi:9606">human</span>
###xml 759 767 <span type="species:ncbi:4896">S. pombe</span>
###xml 792 800 <span type="species:ncbi:4896">S. pombe</span>
###xml 1023 1036 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 1110 1115 <span type="species:ncbi:9606">human</span>
###xml 1251 1256 <span type="species:ncbi:9606">human</span>
###xml 1305 1318 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 1328 1336 <span type="species:ncbi:4896">S. pombe</span>
###xml 1800 1805 <span type="species:ncbi:4932">yeast</span>
Conserved Mechanisms for Regulating DSB Processing by CtIP/Sae2 Orthologues-The data we have obtained through mutating CtIP Thr-847 have a strong resonance with results derived through analyzing the effects of mutating the analogous motif of S. cerevisiae Sae2 (8). It therefore seems that this aspect of CDK-mediated control of DSB processing and repair has been highly conserved throughout evolution. As analogous CDK target sites are present in almost all eukaryotic counterparts of Sae2/CtIP (10-12), it is tempting to speculate that similar control mechanisms operate in diverse eukaryotes to modulate DSB repair pathway choice during the cell cycle. Strikingly, the only Sae2/CtIP homologue known that lacks a site analogous to Thr-847 of human CtIP is S. pombe Ctp1 (9). Nevertheless, S. pombe Ctp1 is phosphorylated on other sites by CDK, and its abundance is strongly regulated during the cell cycle at the transcriptional level, suggesting that these mechanisms serve to control its activity (9, 32). Contrary to S. cerevisiae Sae2, which is constitutively expressed in all phases of the cell cycle, human CtIP is also regulated at the transcriptional level, its amounts being highest in S and G2. It is therefore tempting to speculate that human CtIP combines characteristics exhibited by both S. cerevisiae Sae2 and S. pombe Ctp1. Furthermore, it is noteworthy that the functions of CtIP-interacting proteins such as BRCA1, which promotes CtIP recruitment to sites of DNA damage, and retinoblastoma protein 1 (RB), which controls the G1/S transition, are also cell cycle-regulated (28, 33-35). This suggests that multiple layers of regulation combine to fine-tune CtIP activity during the cell cycle, perhaps to provide even more stringent control of DSB resection than is evident in the yeast systems.
###end p 43
###begin title 44
Supplementary Material
###end title 44
###begin title 45
[Supplemental Data]
###end title 45
###begin p 46
###xml 61 66 <span type="species:ncbi:33453">Julia</span>
We thank Andreas Meier for providing the U2OS-GFP strain and Julia Coates, Jeanine Harrigan, Andreas Meier, Sophie Polo, Yaron Galanty, and Alessandro Sartori for technical advice. We also thank J. Harrigan and K. Dry for critical reading of the manuscript. CtIP and CtIP phospho-Ser-327 antibodies were kindly provided by R. Baer (Columbia University) and X. Yu (University of Michigan Medical School).
###end p 46
###begin p 47
###xml 253 254 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
The abbreviations used are: DSB, double strand break; NHEJ, non-homologous end joining; HR, homologous recombination; CDK, cyclin-dependent kinase; siRNA, small interfering RNA; GFP, green fluorescent protein; DMSO, dimethyl sulfoxide; GST, glutathione S-transferase; PBS, phosphate-buffered saline; IR, ionizing radiation; Gy, grays; GCR, gross chromosomal rearrangement; ssDNA, single-stranded DNA.
###end p 47

